Administration of Gapmer-type Antisense Oligonucleotides Targeting Î³-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts.

Ii, Hiromi; Kasahara, Yuuya; Yamaguma, Harumi; Kageyama, Susumu; Kawauchi, Akihiro; Obika, Satoshi; Nakata, Susumu

Ii, Hiromi; Kasahara, Yuuya; Yamaguma, Harumi; Kageyama, Susumu; Kawauchi, Akihiro; Obika, Satoshi; Nakata, Susumu.

Affiliation

Ii H; Department of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan.
Kasahara Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
Yamaguma H; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
Kageyama S; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
Kawauchi A; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
Obika S; Department of Urology, Shiga University of Medical Science, Shiga, Japan.
Nakata S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan; obika@phs.osaka-u.ac.jp.

Anticancer Res ; 42(3): 1221-1227, 2022 03.

Article de En | MEDLINE | ID: mdl-35220212

Sujet(s)
Mots clés

AMPK; antisense; cyclin-dependent kinase inhibitor; lung cancer; reactive oxygen species; Î³-glutamylcyclotransferase

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oligonucléotides antisens / Prolifération cellulaire / Gamma-glutamylcyclotransferase / Tumeurs du poumon / Antinéoplasiques Limites: Animals / Humans / Male Langue: En Journal: Anticancer Res Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: Grèce

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google